Table 4.

Associations between COVID-19 diagnosis and hypertensive disorders in pregnancy^a

COVID-19 diagnosis according to parity	Hypertensive disorders in pregnancyb (n=266)		Gestational hypertension (n=143)
	Unadjusted	Adjusted	Unadjusted	Adjusted
All mothers
No COVID-19 diagnosis	Ref	Ref	Ref	Ref
COVID-19 diagnosis	1.67 (1.32–2.12)c	1.56 (1.23–1.98)c	1.61 (1.17–2.22)c	1.53 (1.11–2.11)c
Nulliparous
No COVID-19 diagnosis	Ref	Ref	Ref	Ref
COVID-19 diagnosis	2.09 (1.50–2.91)c	1.80 (1.28–2.52)c	2.09 (1.33–3.29)c	1.79 (1.13–2.85)c
Parous
No COVID-19 diagnosis	Ref	Ref	Ref	Ref
COVID-19 diagnosis	1.38 (0.98–1.95)d	1.36 (0.97–1.91)d	1.29 (0.82–2.03)	1.32 (0.84–2.06)

The total numbers reflect the number of participants with complete outcome and covariate data in the final models.

Ref, reference group.

Papageorghiou et al. Preeclampsia and COVID-19. Am J Obstet Gynecol 2021.

^aAdjusted for maternal age, previous parity (nulliparous vs parous), tobacco use during pregnancy, overweight status (normal, underweight, overweight, or obese), or history of diabetes, cardiac disease, hypertension, kidney disease, or adverse pregnancy outcomes

^bIncludes preeclampsia or gestational hypertension

^cP<.05

^dP<.1.